← Back to all earnings calls

VYNE Therapeutics Inc. Q3 FY2024 Earnings Call

Yarrow Bioscience, Inc. (YARW)

Earnings Call FY2024 Q3 Call date: 2024-11-07 Concluded

Share

Quarter scorecard

Revenue

$121,000

+6.1% YoY

Diluted EPS

$-14.50

Net income

-$12.16M

Documents & deck